Q3 2022 13F Holders as of 9/30/2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
112M
-
Number of holders
-
284
-
Total 13F shares, excl. options
-
83M
-
Shares change
-
+2.88M
-
Total reported value, excl. options
-
$6.31B
-
Value change
-
+$223M
-
Put/Call ratio
-
1.52
-
Number of buys
-
115
-
Number of sells
-
-136
-
Price
-
$75.98
Significant Holders of NovoCure Ltd - Common Stock (NVCR) as of Q3 2022
351 filings reported holding NVCR - NovoCure Ltd - Common Stock as of Q3 2022.
NovoCure Ltd - Common Stock (NVCR) has 284 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 83M shares
of 112M outstanding shares and own 74.15% of the company stock.
Largest 10 shareholders include FMR LLC (15.4M shares), Capital World Investors (12.8M shares), BAILLIE GIFFORD & CO (8.91M shares), VANGUARD GROUP INC (8.24M shares), Capital International Investors (7.92M shares), BlackRock Inc. (7.38M shares), STATE STREET CORP (2.62M shares), PRICE T ROWE ASSOCIATES INC /MD/ (2.37M shares), Deep Track Capital, LP (1.29M shares), and GEODE CAPITAL MANAGEMENT, LLC (1.28M shares).
This table shows the top 284 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.